Options for Lowering the Threshold to Brussels Out-of-hours Primary Care Services for Dutch Speaking Citizens
NCT ID: NCT06700980
Last Updated: 2024-12-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
40 participants
OBSERVATIONAL
2024-12-10
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In addition, several technological tools (e.g. video interpreting, translation apps, ...) exist to overcome language barriers. The investigators want to explore which of these options can be used in Brussels out-of-hours primary care services to improve access for Dutch-speaking citizens. The objective of this study is to examine both barriers and facilitators to use these technological translation tools during language-discordant consultations with a French-speaking GP and a Dutch-speaking patient in Brussels out-of-hours primary care services.
To achieve this objective, the investigators aim to engage Dutch-speaking patients, Dutch- and/or French-speaking GPs, as well as Dutch- and/or French-speaking representatives from pertinent organizational and policy sectors.
There will be about 40 participants in total. Participants will answer questions during an online group session (focus group). There will be 4 focus groups, with a maximum of 10 participants in each focus group. Each focus group will last 60-90 minutes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Focus Group
Four groups of participants will meet for online focus groups, identifying barriers and facilitators to the use of technological translation tools in Brussels out-of-hours primary care services for Dutch-speaking patients and French-speaking general practitioners.
Focus Group
Dutch-speaking patients, Dutch- and/or French-speaking general practitioners and Dutch- and/or French-speaking representatives from pertinent organizational and policy sectors will be questioned in heterogeneous focus groups, identifying barriers and facilitators to the use of technological translation tools in Brussels out-of-hours primary care services for Dutch-speaking patients and French-speaking general practitioners.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Focus Group
Dutch-speaking patients, Dutch- and/or French-speaking general practitioners and Dutch- and/or French-speaking representatives from pertinent organizational and policy sectors will be questioned in heterogeneous focus groups, identifying barriers and facilitators to the use of technological translation tools in Brussels out-of-hours primary care services for Dutch-speaking patients and French-speaking general practitioners.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* GPs: adult, working in Brussels, Dutch- and/or French-speaking
* Employees of professional organization-regulatory bodies: adult, Dutch-and/or French-speaking
Exclusion Criteria
* Subject cannot express themself in Dutch or French
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Brusselse Huisartsenkring (BHAK)
UNKNOWN
Vlaamse Gemeenschapscommissie (VGC)
UNKNOWN
Universitair Ziekenhuis Brussel
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Prof. Dr. A. Roex
Role: PRINCIPAL_INVESTIGATOR
Vrije Universiteit Brussel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vrije Universiteit Brussel
Jette, Brussels Capital, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
24366_BruWNed
Identifier Type: -
Identifier Source: org_study_id